Regeneron Pharmaceuticals, Inc. · NASDAQ:REGN
Guarini Kathryn sold 400 Regeneron Pharmaceuticals, Inc. shares (Form 4)
Traded Sep 2, 2026 · Filed Sep 3, 2026
On Sep 2, 2026, Guarini Kathryn (Director) sold 400 Regeneron Pharmaceuticals, Inc. shares at US$850.00 for US$340K under a trading plan, leaving 603 shares. Filed Sep 3, 2026 (Form 4).
- Sold
- 400 shares
- Price
- US$850.00
- Value
- US$340K
- Holding after
- 603 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 2, 2026 | Common Stock | Option exercise | 400 | US$719.37 | 1,003 | Direct |
| Sep 2, 2026 | Common Stock | Sale | 400 | US$850.00 | 603 | Direct |
Source
Related
- Regeneron Pharmaceuticals, Inc.
- Guarini Kathryn
- Regeneron Pharmaceuticals, Inc. shareholders
- Form 4 · Guarini Kathryn · Aug 12, 2026
- Form 4 · Murphy Andrew J · Oct 15, 2026
- Form 4 · McCourt Marion · Sep 3, 2026
- Form 4 · Larosa Joseph J · Aug 21, 2026
- Form 4 · Fenimore Christopher R. · Aug 20, 2026
- Form 4 · Zoghbi Huda Y · Aug 12, 2026